Search results
Arcellx Inc (ACLX) Q1 2024 Earnings: Narrower Losses and Revenue Surge
GuruFocus.com via Yahoo Finance· 3 days agoOperational Highlights: Progress in the development of innovative immunotherapies, including advancements in the anito-cel clinical program for multiple myeloma< ...
Personalis Inc (PSNL) (Q1 2024) Earnings Call Transcript Highlights: Surpassing Revenue ...
GuruFocus.com via Yahoo Finance· 4 days agoWe also anticipate New York approval for both tests, positioning us well within the regulatory framework. Q: Following the recent AdCom meeting on MRD as an endpoint in multiple< ...
Canaccord Genuity Group Cuts 2seventy bio (NASDAQ:TSVT) Price Target to $11.00
ETF DAILY NEWS· 1 day ago2seventy bio (NASDAQ:TSVT – Free Report) had its target price lowered by Canaccord Genuity Group from $12.00 to $11.00 in a research note issued to investors on Thursday morning, Benzinga reports ...
Single-Cell Multi-Omics Analysis of IASO Bio's Equecabtagene Autoleucel in the Treatment of...
WTNH-TV New Haven· 2 days agoOn May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of...
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoKaryopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript May 8, 2024 Karyopharm...
Spurs' Land, Elliott get mixed reviews in NBA announcer rankings
San Antonio Express-News· 7 days agoSports media news site Awful Announcing revived its local NBA announcer rankings last week, and the...
Karyopharm Therapeutics Inc (KPTI) Q1 2024 Earnings Call Transcr
Guru Focus· 4 days agoKaryopharm Therapeutics Inc (KPTI) has successfully refinanced its debt, extending maturities to 2028 and 2029, which aligns well beyond the expected data readouts and potential approvals of ...
Salem Farmer's Market back for another season
The Eagle-Tribune· 2 days agoSUNDAY, MAY 12
Adaptive Biotechnologies Corp (ADPT) Q1 2024 Earnings Call Trans
Guru Focus· 6 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Adaptive Biotechnologies Corp (ADPT, Financial) reported a strong revenue growth of 52% in ...
Adaptive Biotechnologies Q1 2024 Earnings: Revenue Beats Estimates Amidst Challenges
GuruFocus.com via Yahoo Finance· 5 days agoIts flagship product, clonoSEQ, is an FDA-authorized test used for detecting and monitoring minimal residual disease (MRD) in various cancers, including multiple ...